sodium 3,5-dibromo-4-phenolsulfonate | 21886-86-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: sodium 3,5-dibromo-4-phenolsulfonate
• 英文别名: 3,5-dibromo-4-hydroxy-benzenesulfonic acid ; sodium-salt；3,5-Dibrom-4-hydroxy-benzolsulfonsaeure; Natrium-Salz；sodium 3,5-dibromo-4-hydroxybenzenesulfonate；3,5-Dibrom-4-hydroxy-benzolsulfonsaeure；Sodium;2,6-dibromo-4-sulfophenolate；sodium;2,6-dibromo-4-sulfophenolate
• CAS: 21886-86-2
• 化学式: C₆H₃Br₂O₄S*Na
• 分子量: 353.951
• InChiKey: PBAQEHZYPFSMER-UHFFFAOYSA-M

计算性质

• 辛醇/水分配系数(LogP)：
  -1.17
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  85.8
• 氢给体数：
  1
• 氢受体数：
  4

安全信息

• 海关编码：
  2908999090

反应信息

• 作为反应物：
  描述：

  sodium 3,5-dibromo-4-phenolsulfonate 在 五氯化磷 、 三氯氧磷 作用下， 生成 3,5-二溴-4-羟基苯磺酰氯
  参考文献：
  名称：

  3,5-二溴-4-羟基苯磺酰氯与弱碱的反应（“醌亚砜”中间体问题）

  摘要：

  通过跟踪反应混合物的紫外光谱，研究了在 3,5-二溴-4-羟基苯磺酰氯与弱碱反应过程中“醌型亚砜”中间体 II 的形成。已经表明作为反应最终产物形成的无色沉淀物是低聚物并且具有结构 V。

  DOI：

  10.1246/bcsj.38.1543
• 作为产物：
  描述：

  alkaline earth salt of/the/ methylsulfuric acid 在 盐酸 、 sodium bromate 、 sodium bromide 作用下， 生成 sodium 3,5-dibromo-4-phenolsulfonate
  参考文献：
  名称：

  The Bromodesulfonation of Aromatic Sulfonate Salts. II. The Effect of Amino, Methoxy, Methyl and Nitro Substituents¹

  摘要：

  DOI：

  10.1021/ja01568a064

文献信息

• CARBOXY ESTER KETALS, METHODS OF MANUFACTURE, AND USES THEREOF
  申请人：SEGETIS, INC.

  公开号：US20140147395A1

  公开（公告）日：2014-05-29

  This disclosure is directed to compound of formula (1): wherein R 1 is a C 7-18 alkyl, R 2 is hydrogen or a C 1-3 alkyl, each R 3 , R 4 , R 5 , R 6 , and R 7 is independently hydrogen or a C 1-6 alkyl, a is 2-3, and b is 0-1, its method of preparation and uses thereof in water-borne coating compositions, cleaning compositions, fragrance, and personal care compositions.

  这项披露涉及到化合物的结构式(1)：其中R1是C7-18烷基，R2是氢或C1-3烷基，每个R3、R4、R5、R6和R7独立地是氢或C1-6烷基，a为2-3，b为0-1，以及其在水性涂料组合物、清洁组合物、香料和个人护理组合物中的制备方法和用途。
• Sheet or tubular structure consisting of elastic biocompatible material and its use
  申请人：Charité - Universitätsmedizin Berlin

  公开号：EP2067494A1

  公开（公告）日：2009-06-10

  The present invention relates to a sheet or tubular structure consisting of biocompatible material, which is elastic and comprises at least one biologically active substance in at least one region and to a sheet or tubular structure, which comprises at least one biologically active substance release-modifying agent in at least one region as well as an implant covered at least partially by the sheet or tubular structure of the invention. The present invention further provides a method and an apparatus for producing, and preferably customizing and/or optimizing, the sheet or tubular structure of the invention. The sheet or tubular structure of the invention can be customized/optimized before implantation in the operating room.

  本发明涉及一种由生物相容性材料构成的片状或管状结构，该结构具有弹性，并在至少一个区域中包含至少一种生物活性物质；本发明还涉及一种片状或管状结构，该结构在至少一个区域中包含至少一种生物活性物质释放调节剂，以及至少部分由本发明的片状或管状结构覆盖的植入物。本发明进一步提供了一种生产本发明片状或管状结构的方法和设备，最好是定制和/或优化本发明片状或管状结构的方法和设备。本发明的片状或管状结构可在手术室植入前进行定制/优化。
• MICROPARTICLE FOR RELEASING AN ACITVE AGENT
  申请人：Biomod Concepts Inc.

  公开号：EP3434264A1

  公开（公告）日：2019-01-30

  The present invention relates to articles of manufacture having a formulation distributed therein, wherein the formulation comprises an active agent which manifests a desirable property when released from the articles of manufacture. The present invention also relates to methods for manufacturing these articles of manufacture, to vehicles for applying the formulation to these articles of manufacture, and to perception indicators indicating the presence and the amount of formulation comprising an active agent applied to an article of manufacture.

  本发明涉及具有分布在其中的制剂的制成品，其中制剂包括一种活性剂，当活性剂从制成品中释放出来时，表现出一种理想的特性。本发明还涉及制造这些制成品的方法、将制剂应用于这些制成品的载体，以及指示应用于制成品的包含活性剂的制剂的存在和数量的感知指标。
• MICRODRESSINGS FOR SKIN TREATMENT
  申请人：Cytrellis Biosystems, Inc.

  公开号：EP3456300A1

  公开（公告）日：2019-03-20

  The present invention relates to microclosures and methods for treating microwounds in the skin (e.g., after incising or excising tissue portions from a subject). Exemplary microclosures include a material having at least one dimension of from about 10 um to about 1 mm after application to a microwound. The microclosure maintains a first compressive force when applied to the microwound.

  本发明涉及用于治疗皮肤微小伤口（例如，在从受试者身上切开或切除组织部分后）的微容器和方法。示例性微封闭体包括一种材料，该材料在应用到微伤口后至少有一个尺寸为约10微米到约1毫米。当施加到微伤口上时，微外壳保持第一压缩力。
• Methods and devices for skin tightening
  申请人：Cytrellis Biosystems, Inc.

  公开号：US10251792B2

  公开（公告）日：2019-04-09

  The present invention relates to methods and devices for skin tightening after incising or excising tissue portions from a subject. Exemplary methods and devices include tunable dressings having an adhesive layer and a regulatable layer or an un-stretched layer that responds to one or more external stimuli to contract or expand the dressing, where the contraction or expansion can be uniform or non-uniform.

  本发明涉及从受试者身上切开或切除组织部分后紧致皮肤的方法和装置。示例性方法和装置包括可调敷料，该敷料具有粘合层和可调节层或未拉伸层，可对一种或多种外部刺激做出反应，使敷料收缩或膨胀，收缩或膨胀可以是均匀的，也可以是非均匀的。